Gene therapy clinical trials

Gene: SPINK5

Green List (high evidence)

SPINK5 (serine peptidase inhibitor, Kazal type 5)
EnsemblGeneIds (GRCh38): ENSG00000133710
EnsemblGeneIds (GRCh37): ENSG00000133710
OMIM: 605010, Gene2Phenotype
SPINK5 is in 9 panels

1 review

Ellen McDonagh (Genomics England Curator)

Green List (high evidence)

Genetic: One 20cm2/10cm2 autologous skin sheet graft - https://clinicaltrials.gov/ct2/show/NCT01545323
Created: 12 May 2018, 8:57 a.m.

Phenotypes
Netherton syndrome

History Filter Activity

12 May 2018, Gel status: 4

Added New Source

Ellen McDonagh (Genomics England Curator)

SPINK5 was added to Gene therapy clinical trials panel. Sources: ClinicalTrials.gov,Expert Review Green

12 May 2018, Gel status: 4

Created

Ellen McDonagh (Genomics England Curator)

SPINK5 was created by Ellen McDonagh